The Effect of Mesotherapy and Intra-articular Steroid Injection in Shoulder Pain
NCT ID: NCT06610032
Last Updated: 2024-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2024-07-01
2024-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mesotherapy
A total of 3 sessions of mesotherapy will be applied to the shoulder area, 7 days apart.
Mesotherapy
A total of 3 sessions of mesotherapy will be applied to the shoulder area of the patients, 7 days apart in group 1.
Steroid
A single-session intra-articular 20 mg triamcinolone hexacetonide injection will be administered.
Intra-articular steroid injection
Single session intra-articular 20 mg triamcinolone hexacetonide injection will be applied for patients in group 2.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mesotherapy
A total of 3 sessions of mesotherapy will be applied to the shoulder area of the patients, 7 days apart in group 1.
Intra-articular steroid injection
Single session intra-articular 20 mg triamcinolone hexacetonide injection will be applied for patients in group 2.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Having shoulder pain for 6 months
3. VAS (Visual Analog Scale) \> 4
4. Patients who can receive verbal instructions and do not have cognitive deficits
Exclusion Criteria
2. Having had a shoulder joint injection in the last 3 months
3. History of previous upper extremity surgery
4. History of drug allergy
5. Use of anticoagulant drugs (warfarin, low molecular weight heparin), patients with coagulation disorder
6. History of malignancy
7. Psychiatric illness
8. A rheumatological diagnosis such as Polymyalgia Rheumatica, Rheumatoid Arthritis, Ankylosing Spondylitis
9. Kidney failure
10. Liver disease
11. Heart failure
12. Pregnancy
13. Presence of infection, wound, allergy, burn-like lesions in the application area
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haydarpasa Numune Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ecem Pelin Kaymaz
Medical Doctor of Physical Medicine and Rehabilitation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Science University Haydarpasa Numune Research and Training Hospital
Istanbul, Üsküdar, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mammucari M, Gatti A, Maggiori S, Sabato AF. Role of mesotherapy in musculoskeletal pain: opinions from the italian society of mesotherapy. Evid Based Complement Alternat Med. 2012;2012:436959. doi: 10.1155/2012/436959. Epub 2012 May 13.
Faetani L, Ghizzoni D, Ammendolia A, Costantino C. Safety and efficacy of mesotherapy in musculoskeletal disorders: A systematic review of randomized controlled trials with meta-analysis. J Rehabil Med. 2021 Apr 27;53(4):jrm00182. doi: 10.2340/16501977-2817.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMU-GETAT-EK 05/27.03.2024
Identifier Type: -
Identifier Source: org_study_id